CLINICAL_TRIALS
trial_result
· 2014-08-26
Clinical Trial Update: A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of Alefacept in chronic plaque psoriasis patients who failed or were unsuitable for conventional therapy has co…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Chronic Plaque Psoriasis | Phase 3 | Status: COMPLETED